科华智慧（深圳）创新药物研发有限公司-天然产物化合物库-创新药物研发-波谱智能解析-化合物冷冻电镜结构解析

天然产物数据库

您可快速检索70万⁺天然产物信息

检索最多: 白僵菌素大品种冬虫夏草人参三七党参大戟决明半夏丁香

CAS No.	英文名/中文名/SMILES	分子式	分子量
-	7-[(2,4-dimethoxyphenyl)methylidene]-3-[(3R)-1,1-dioxothiolan-3-yl]-9-methyl-2,4-dihydrofuro[3,2-g][1,3]benzoxazin-6-one - CC1=C2C(=CC3=C1OC(=CC4=C(C=C(C=C4)OC)OC)C3=O)CN(CO2)[C@@H]5CCS(=O)(=O)C5	C₂₄H₂₅NO₇S	471.5
-	1',6'-Dimethyl-4'-oxo-N-(2-phenylethyl)-3',4'-dihydro-1'H-spiro[piperidine-4,2'-quinazoline]-1-carboxamide - CC1=CC2=C(C=C1)N(C3(CCN(CC3)C(=O)NCCC4=CC=CC=C4)NC2=O)C	C₂₃H₂₈N₄O₂	392.5
-	[2-[(3S,5S,8R,9S,10S,13S,14S,17R)-3,17-diacetyloxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate - CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C)OC(=O)C	C₂₇H₄₀O₇	476.6
-	3-[[6-hydroxy-5,8a-dimethyl-2-methylidene-5-(4-methylpent-3-enyl)-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]methyl]-2-methoxy-5,6-dimethylpyran-4-one - CC1=C(OC(=C(C1=O)CC2C(=C)CCC3C2(CCC(C3(C)CCC=C(C)C)O)C)OC)C	C₂₈H₄₂O₄	442.6
-	N-[(4-methoxyphenyl)methyl]-N'-(4-pentoxyphenyl)oxamide - CCCCCOC1=CC=C(C=C1)NC(=O)C(=O)NCC2=CC=C(C=C2)OC	C₂₁H₂₆N₂O₄	370.4
-	(1S,3R,4R,5S,8R,10R,14S)-10,14-dimethyl-5-[(4-pyrimidin-2-ylpiperazin-1-yl)methyl]-2,7-dioxatetracyclo[8.4.0.01,3.04,8]tetradecan-6-one - C[C@H]1CCC[C@]2([C@]13[C@H](O3)[C@H]4[C@@H](C2)OC(=O)[C@@H]4CN5CCN(CC5)C6=NC=CC=N6)C	C₂₃H₃₂N₄O₃	412.5
-	16,17-dimethoxy-5-[(2S)-1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl]oxy-1,11-diazapentacyclo[10.7.1.02,7.08,20.013,18]icosa-2(7),3,5,8(20),9,11,13(18),14,16-nonaen-19-one - C[C@@H](C(=O)N1CCN(CC1)C2=CC=CC=C2)OC3=CC4=C(C=C3)N5C6=C4C=CN=C6C7=C(C5=O)C(=C(C=C7)OC)OC	C₃₃H₃₀N₄O₅	562.6
40657-57-6	Dodec-4-en-2-one - CCCCCCCC=CCC(=O)C	C₁₂H₂₂O	182.30
-	[4-Bromo-2-[3-(2-methoxyphenyl)prop-2-enoyl]phenyl] 3,4-dimethoxybenzoate - COC1=C(C=C(C=C1)C(=O)OC2=C(C=C(C=C2)Br)C(=O)C=CC3=CC=CC=C3OC)OC	C₂₅H₂₁BRO₆	497.3
-	(3R,6E)-3-benzyl-6-benzylidenepiperazine-2,5-dione - C1=CC=C(C=C1)C[C@@H]2C(=O)N/C(=C/C3=CC=CC=C3)/C(=O)N2	C₁₈H₁₆N₂O₂	292.3